S.A.V.E. Studi Analisi Valutazioni Economiche Srl is a research, consulting, and training company in Health Economics, Pharmacoeconomics, and Outcomes Research. It was founded in Milan in 1994, as a first crossroad between theoretical heritage, academic models, and business experience in Italy. S.A.V.E. offers multiple tools to support decision-making processes within Institutions and companies and for professionals in the healthcare and pharmaceutical sectors, aiming at exploiting resources more effectively.
S.A.V.E. Studi research center is a founding partner, together with the University of Pavia, of CEFAT Center of Pharmaceuticals Economics and Medical Technologies Evaluation which carries out research in the field of Real World Data (RWD) and Real World Evidence (RWE) and their applications to the pharmaceutical market, medical devices and life sciences industries.
In collaboration with University of Pavia - Department of Drugs Science, S.A.V.E organize and support the postgraduate Master (MAMAF) on Marketing management in the pharmaceutical industry.
S.A.V.E official journal is ClinicoEconomics - Italian Articles on Outcomes Research Journal, and in collaboration with Making Life Srl offers reprints and customized layouts of the published articles.
S.A.V.E. is active in the fields of pharmacoeconomics, outcomes research and HTA, and offers tools to define, measure, and communicate the economic evidence of a product (drug and medical device) or treatment pathway. In that sense, academic research and consulting strategies work in synergy to offer an exhaustive and functional picture of the clients’ needs.
Pricing and Reimbursement
Social and health cost studies of a disease (quantification of consumed resources and determination of the costs of managing some types of patients, borne by the national health service and society as a whole)
Definition of the Value Dossier to negotiate price and reimbursement with national, regional and local health authorities
Preparation of cost studies for Quality Adjusted Life Years (QALYs), Cost Minimization Analysis (CMA), Cost Benefit Analysis (CBA), Cost Effectiveness Analysis (CEA), Cost Utility Analysis (CUA), Budget Impact Analysis (BIA)
Analysis, assessment and creation of clinical pathways on new or existing therapies and of diagnostic pathways for the treatment of certain diseases
Impact of the new drug on the diagnostic-therapeutic pathway for different disease as cardiovascular, gastroenterological, neurologic, infective, etc.
Economic models and disease modelling, created both with institutional, externally validated criteria, and as easy-to-use tools to support marketing, customized software and development of specific apps.
Customization and adaptation of models to specific national, regional and local contexts
Possibility to compare prices at a central and regional level and european level
Real-time update of cost, epidemiological and effectiveness data
Possibility to continuously update the results of budget-impact and cost-effectiveness models
Exclusive use of the disease modeling platform savedigital ® available to: decision-makers, physicians/clinicians interested in creating and updating databases in real time, payers, Market Access managers, pharmacoeconomic decision makers
Governance systems and organizational tools for monitoring and evaluating the appropriateness of pharmaceutical and healthcare expenditure
Pharmacoeconomic analyses on data from Banca Dati Assistito (BDA) – Integrated Patients Database e Patients Registry
Support with Real World Data (RWD) for a national and regional planning and programming of pharmaceutical and health expenditure based on Real World Evidence (RWE)
Definition of specific indicators and permanent observers of populations and evaluation of the use of drugs and medical devices in terms of Outcomes Research
Statistical and economic analyses within research protocols, clinical databases and observational registries of patients
Complete economic evaluations: WTP Analysis, Cost Minimization Analysis (CMA), Cost Benefit Analysis (CBA), Cost Effectiveness Analysis (CEA), Cost Utility Analysis (CUA), Quality Adjusted Life Years (QALYs), Budget Impact Analysis (BIA)
Definition and planning of pharmacoeconomic research protocols and CRF planning
Applied research on social and health policies
SAVE carries out research activities in the field of Real World Data (RWD) and Real World Evidence (RWE), together with the University of Pavia, as founding partner of CEFAT, with reference to:
Systematic literature reviews of outcomes research, pharmacoeconomics and HTA Heath Technology Assessment
Original research contributions, methodological essays in the field of HTA
Scientific posters and products for communication and presentation at dedicated workshops, medical congresses, international meetings
Participation in scientific workshops, symposia and congresses
Processing of clients’ proposals, work completion, and organization and control of the phases of submission and review of scientific work in the pharmacoeconomic field
Health Economics & Outcomes Research contents for institutional reports and supporting the marketing/sales process
S.A.V.E. carries out training and updating activities for professionals in the social-health and pharmaceutical sectors, as a natural carryover of its work in research and consulting. S.A.V.E. defines study seminars and workshops, and participates in congresses, in constant partnership with other national and international scientific bodies. The contents of the various subject areas are defined by constantly tackling the discussed themes in the S.A.V.E. research fields and considering suggestions from the social-health sector which are functional to Market Access activities. It is possible to request targeted programs for the in-depth analysis of specific interesting themes for a certain group of professionals, or choose the most functional plan in view of the nature of the program to be implemented (internal seminar, residential day of study, distance learning, workshop, frontal lectures).
Italian Articles on Outcomes Research
Clinico Economics is a peer-reviewed pharmacoeconomics and outcomes research journal on the economic and health-policy consequences of medical devices and pharmacological strategies.
VISIT THE WEBSITE OF THE JOURNAL
University partners: Università degli Studi di Pavia
Center of Pharmaceuticals Economics and Medical Technologies Evaluation
Postgraduate Master on Marketing management in the pharmaceutical industry MAMAF
At S.A.V.E., the staff is composed of a strong group of researchers and professionals who are hands-on in the medical, pharmaceutical, economic and statistical fields, as well as in social-health policies and risk management. All partners and members of the scientific ethic committee are actively involved in academia and have an ongoing scientific relationship with their university departments and institutes. S.A.V.E. also cooperates with a large network of external consultants, built up in 20 years of activity through synergies developed with academia, institutions, clinicians, and research organizations, at a national and international level. S.A.V.E. scientific director is Prof. Giorgio L. Colombo.
Argon Healthcare Italia
Biogen – Dompè
CD pharma group
Hill+Knowlton strategies Italy
IMS Health information solution Italy
Johnson & Johnson Medical
McCann Complete Medical
Otsuka Pharmaceutical Italy
Pierre Fabre Pharma
Procter & Gamble
Sankyo Pharma Italia
Sanofi Pasteur MSD
Swiss Medical Care
Therabel GiEnne Pharma
Public and Academic Institutions
Accademia Nazionale di Medicina
Ass. Lombarda Titolari di Farmacia
Centro Studi e Ricerche sulla Famiglia, Milano
Ist. Malattie Infettive e Medicina Pubblica
Réseau Européen des Instituts de la Famille
Università Cattolica del Sacro Cuore, Milano
Università degli Studi di Pavia
ISS Istituto Superiore di Sanità
Ministero della Salute
No Profit Organizations
ASBI, Associazione Italiana Spina Bifida
Aragorn, iniziative per il no-profit
Rotary Club Bollate Nirone
MAGIS ITALIA - Gesuiti Missionari Italiani
Hospitals And Clinical Organizations
AIOM - Associazione Italiana di Oncologia Medica
Azienda Ospedaliera G. Salvini, Garbagnate Milanese
Azienda Ospedaliera di Busto Arsizio, Varese
Azienda Ospedaliera Niguarda Ca’ Granda
Ospedale Caduti Bollatesi
Clinica Morgagni, Catania
Ager, Associazione per la ricerca geriatrica e lo studio della longevità
Dove Medical Press
Fondazione Leonardo, Milano
Ismu, Iniziative e studi sulla multietnicità